Dietrich John Pauls

All filings by Dietrich John Pauls on record concern DiaMedica Therapeutics Inc., in the capacity of chief executive. In total, 4 filings cover trades dated from 16 August 2021 to 10 August 2026.

Purchases make up the whole of the open-market record (3 purchases, €82k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.

Half of the purchases are above €23k and half below. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 12 August 2026, the filings show a share grant in DiaMedica Therapeutics Inc. The clock since the last published purchase (26 June 2023) now reads 1,210 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.